A Study of TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection

Clinical trial NCT01366638 · COMPLETED

Trial details

NCT number: NCT01366638
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2011-05-01
Primary completion: 2012-11-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.